SYST-04 PRELIMINARY REPORT OF A CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICIENCY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: A PROSPECTIVE, PHASE II, SINGLE-ARM STUDY

High-grade glioma is the most common malignant primary brain tumor in the central nervous system. Multiple strategies such as surgery, radiotherapy, and chemotherapy have been used, but the prognosis of patients with high-grade glioma remains poor. No standard treatment exists for recurrent gliomas;...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Fuhua, Guo, Chengcheng, Yang, Qunying, Chen, Yinsheng, Ke, Chao, Sai, Ke, Zhang, Ji, Jiang, Xiaobing, Hu, Wanming, Xi, Shaoyan, Zhou, Jian, Li, Depei, Zhou, Zhihuan, Zhao, Qinqin, Cao, Xi, Chen, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354216/
http://dx.doi.org/10.1093/noajnl/vdac078.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354216/
http://dx.doi.org/10.1093/noajnl/vdac078.083

Ejemplares similares